INSIGHTS ON DRUG DEVELOPMENT

• NGS In GMP Manufacturing: Reducing Risk, Increasing Return

  Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.

• Discovery Core Rheometer: Easy To Use. Hard To Beat.

  Explore how advanced rheological testing delivers deeper insight into material behavior, from flow and yield stress to quality control decisions, using guided workflows that simplify setup.

• Why Pharmaceutical Scientists Trust The Discovery Core Rheometer

  Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.

• Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development

  Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.

• Patient-Centric Formulations In Pediatric Adherence

  11/13/2025

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk

  8/20/2026

  Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.

• Navigating Drug Design In 'Beyond The Rule Of 5' Landscape

  6/17/2026

  New drug modalities are transforming treatment but bring new challenges. See how hybrid approaches that combine biologics and chemistry are redefining the design of innovative therapies.

• How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

  9/2/2025

  CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.

• Understanding Adeno-Associated Virus Vector Impurities

  11/13/2025

  AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.